Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: To assess the efficacy of ivermectin in addition to standard treatment compared to standard treatment alone in reducing hospitalizations in the COVID-19 patient population. TRIAL DESIGN: IVERCOR-COVID19 will be a single-center, prospective, randomized, double-blind, parallel group (1:1 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejos, Julio, Zoni, Rodrigo, Bangher, Maria, Villamandos, Silvina, Bobadilla, Angelina, Plano, Fabian, Campias, Claudia, Chaparro Campias, Evangelina, Achinelli, Fernando, Guglielmone, Hector A., Ojeda, Jorge, Medina, Fernanda, Farizano Salazar, Diego, Andino, Gerardo, Ruiz Diaz, Natalia E., Kawerin, Pablo, Meza, Elba, Dellamea, Silvana, Aquino, Antonia, Flores, Victor, Martemucci, Carolina N., Vernengo, María Mercedes, Martinez, Silvina María, Segovia, Juan Emanuel, Aguirre, María Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683865/
https://www.ncbi.nlm.nih.gov/pubmed/33234158
http://dx.doi.org/10.1186/s13063-020-04813-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683865/
https://www.ncbi.nlm.nih.gov/pubmed/33234158
http://dx.doi.org/10.1186/s13063-020-04813-1

Ejemplares similares